15:30 | Infectious uveitis secondary to immunosuppression : Real-life experience from Montreal, Canada | AUBIN MJ | ||
15:38 | Questions / Discussion | |||
15:40 | Biosimilars in uveitis | GOLDSTEIN D | ||
15:48 | Questions / Discussion | |||
15:50 | Systemic anti-IL-6 therapy in uveitis | FORTIN E | ||
15:58 | Questions / Discussion | |||
16:00 | Economic evaluation of DMARDs and biologics for treatment of non-infectious uveitis: A Canadian Perspective | DERZKO-DZULYNSKY L | ||
16:08 | Questions / Discussion | |||
16:10 | Outcomes of Immunosuppression in Paediatric Patients with Non-Infectious Uveitis: A Real-World Experience | VADBONCOEUR J | ||
16:18 | Questions / Discussion | |||
16:20 | Personalized approach to immunosuppression | PICHI F | ||
16:28 | Questions / Discussion | |||
16:30 | End of Session |